There is so much potential in this stock.
I dont agree on the long term basis however.
From what we have been provided, NTI has shown substantially positive results.
Dependent on the final announcement gateways may be opened for FDA.
CR is annoying however, it is good to see management raising money for further testing and to push the product.
In the bottom drawer... once again.
GLTA
DMD
